By Sabrina Richards / Fred Hutch News Service
By Diane Mapes / Fred Hutch News Service
Each October in the U.S., women are accustomed to hearing messages about early detection and breast cancer awareness. But what’s the best way to raise breast cancer awareness in countries with no mammogram machines and few cancer treatment centers?
Longtime leader in global cancer control Dr. Ben Anderson was just awarded $550,000 by Susan G. Komen to further his work with the Breast Health Global Initiative, or BHGI, an international health alliance founded by Fred Hutch and the Komen organization.
Geekwire: University of Washington Initiative Awarded $9.3M to Fight Deadly Malaria Strains in India
By Clare McGrane
Viruses and parasites are constantly changing. That’s the reason last year’s flu shot isn’t as effective against this year’s flu — the virus has evolved to resist it.
The same is true for malaria, but unlike the flu, malaria is one of the most deadly parasites in the world, and it’s becoming resistant to the lifesaving drugs that can cure it.
By Mary Engel
A Fred Hutch and University of Washington team of virologists and bioengineers led by Dr. Keith Jerome has received a $200,000 grant — the first phase of up to $1.5 million in milestone-driven funding over four years — to develop nanocarrier technology to deliver therapies to reservoirs of dormant, HIV-infected cells.
Julie Overbaugh, PhD, Affiliate Professor in the UW Department of Global Health, scientist and member at the Fred Hutchinson Cancer Research Center, and Endowed Chair of Graduate Education, received the lifetime achievement Nature Award for Mentoring in Science and a $10,000 prize in December. Nature hosts these annual awards to champion the importance of mentoring and inspiring a generation of young scientists.
By Jessica Berman
A genetically engineered malaria vaccine has been shown to prevent the disease in mice, researchers say. The findings offer hope of halting the illness in humans, as well as stopping transmission of the mosquito-borne disease.
Researchers at the Center for Infectious Disease Research (CIDR) at the University of Washington, in conjunction with the Fred Hutchison Cancer Research Center, have developed a vaccine that uses the entire malaria-causing parasite — called P. falciparum — to stimulate a protective immune response.
By Mary Engel
Researchers may be one step closer to a truly effective malaria vaccine, a new study suggests. A genetically modified malaria parasite worked as designed in its first human clinical trial, causing neither malaria nor serious safety problems in the 10 people who volunteered to be infected. It also stimulated an immune response that holds out promise of a more protective vaccine than the single candidate now in pilot studies
New data analyses finds that a monthly vaginal ring containing an antiretroviral drug called dapivirine can cut women’s HIV risk by more than half and, in some, by 75 percent or more.
One of the researchers, Jared Baeten, a University of Washington professor of epidemiology, medicine and global health, presented the results Tuesday at the AIDS 2016 conference in Durban, South Africa.